Responses
Regular and young investigator award abstracts
Immunotherapy toxicities
649 Incidence of thromboembolism (TE) in patients with melanoma receiving immune checkpoint inhibitor (ICI) therapy and its adverse impact on survival
Compose a Response to This Article
Other responses
No responses have been published for this article.